Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Entrada Therapeutics (TRDA) Shares Issued (2022 - 2025)

Historic Shares Issued for Entrada Therapeutics (TRDA) over the last 4 years, with Q3 2025 value amounting to $8000.0.

  • Entrada Therapeutics' Shares Issued rose 10204.08% to $8000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$96.4 million, marking a year-over-year decrease of 19640.85%. This contributed to the annual value of $2.8 million for FY2024, which is 13437.24% up from last year.
  • As of Q3 2025, Entrada Therapeutics' Shares Issued stood at $8000.0, which was up 10204.08% from $20000.0 recorded in Q2 2025.
  • Entrada Therapeutics' Shares Issued's 5-year high stood at $99.8 million during Q2 2024, with a 5-year trough of -$96.8 million in Q4 2024.
  • For the 4-year period, Entrada Therapeutics' Shares Issued averaged around $308733.3, with its median value being $60000.0 (2022).
  • Within the past 5 years, the most significant YoY rise in Entrada Therapeutics' Shares Issued was 3871400.0% (2023), while the steepest drop was 17301818.18% (2023).
  • Quarter analysis of 4 years shows Entrada Therapeutics' Shares Issued stood at $163000.0 in 2022, then surged by 165.64% to $433000.0 in 2023, then crashed by 22461.66% to -$96.8 million in 2024, then skyrocketed by 100.01% to $8000.0 in 2025.
  • Its Shares Issued was $8000.0 in Q3 2025, compared to $20000.0 in Q2 2025 and $350000.0 in Q1 2025.